Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Osteoporosis
What degree of treatment related hypocalcemia would you tolerate with denosumab before switching agents?
Related Questions
Do you start bisphosphonates after tapering off menopausal hormone therapy to prevent the rapid decline of bone mineral density?
What is the preferred osteoporosis therapy after completing teriparatide in a young woman planning pregnancy within the next year?
Are SGLT2 inhibitors contraindicated in patients with osteoporosis and history of vertebral and hip fractures?
How do you manage hypercalcemia in an osteoporosis patient on a PTH analogue?
How would you manage a patient who has been on denosumab for 7 years and is now found to have progressive bony erosions of the external auditory canal, which the treating neurotologist suspects are secondary to denosumab?
When should bone biopsy be considered to guide management in patients in whom you're differentiating osteoporosis and renal osteodystrophy?
Do you find trabecular bone score (TBS) useful in patients with a history of ankylosing spondylitis when screening for vertebral fracture risk?
How does an incidental finding of low bone density on imaging done for another reason inform your screening approach for osteoporosis?
Is Evenity appropriate for a patient with severe osteoporosis (T-score -3.1) unresponsive to bisphosphonates and persistent primary hyperparathyroidism despite two surgeries?
Is there a maximum duration for raloxifene use?
